NCT00171977View on ClinicalTrials.gov

Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST)

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

April 30, 2009

Conditions
Gastrointestinal Stromal Tumors
Interventions
DRUG

Imatinib Mesylate

Trial Locations (1)

Unknown

Novartis Investigative Site, Tokyo

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY